- Home
- FMS vs RVTY Comparison
FMS vs RVTY Comparison
Compare FMS & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMS
- RVTY
- Stock Information
- Founded
- FMS 1996
- RVTY 1937
- Country
- FMS Germany
- RVTY United States
- Employees
- FMS N/A
- RVTY N/A
- Industry
- FMS Misc Health and Biotechnology Services
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- FMS Health Care
- RVTY Industrials
- Exchange
- FMS Nasdaq
- RVTY Nasdaq
- Market Cap
- FMS 13.4B
- RVTY 13.9B
- IPO Year
- FMS 1996
- RVTY N/A
- Fundamental
- Price
- FMS $24.64
- RVTY $123.15
- Analyst Decision
- FMS Hold
- RVTY Buy
- Analyst Count
- FMS 1
- RVTY 12
- Target Price
- FMS $25.00
- RVTY $133.00
- AVG Volume (30 Days)
- FMS 213.3K
- RVTY 648.7K
- Earning Date
- FMS 02-25-2025
- RVTY 01-31-2025
- Dividend Yield
- FMS 2.58%
- RVTY 0.23%
- EPS Growth
- FMS 46.47
- RVTY N/A
- EPS
- FMS 2.50
- RVTY 2.06
- Revenue
- FMS $21,457,738,113.00
- RVTY $2,721,555,000.00
- Revenue This Year
- FMS N/A
- RVTY $2.20
- Revenue Next Year
- FMS $3.88
- RVTY $4.98
- P/E Ratio
- FMS $19.37
- RVTY $59.65
- Revenue Growth
- FMS N/A
- RVTY N/A
- 52 Week Low
- FMS $17.93
- RVTY $97.32
- 52 Week High
- FMS $24.67
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- FMS 72.34
- RVTY 62.31
- Support Level
- FMS $22.90
- RVTY $119.06
- Resistance Level
- FMS $23.27
- RVTY $124.17
- Average True Range (ATR)
- FMS 0.29
- RVTY 3.60
- MACD
- FMS 0.18
- RVTY 0.83
- Stochastic Oscillator
- FMS 98.66
- RVTY 89.61
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.